Keymed Biosciences Inc. (HKG:2162)

Hong Kong · Delayed Price · Currency is HKD

73.55

-1.15 (-1.54%)

Aug 19, 2025, 2:45 PM HKT

Revenue by Product

Fiscal year is January - December.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Biopharmaceutical Research & Development and Commercialisation	464.18M	Log In	Log In	Log In
Biopharmaceutical Research & Development and Commercialisation Growth	18.63%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Year Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Overseas	424.09M	Log In	Log In	Log In
Overseas Growth	8.67%	Log In	Log In	Log In
China	40.09M	Log In	Log In	Log In
China Growth	3917.60%	Log In	Log In	Log In